← Open Payments lookup

MARVIN PEYTON: Open Payments

NPI 1578644803 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$17,310 in 62 payments from 12 companies in 2025. Trend: 2023 $9,048 · 2024 $25,435 · 2025 $17,310

Honoraria: $11,000Travel & lodging: $4,363Food & beverage: $1,947
CompanyPaymentsAmount
Axsome Therapeutics, Inc.18$13,056
Neurocrine BioSciences, Inc.14$2,414
Boehringer Ingelheim Pharmaceuticals, Inc.9$1,461
Teva Pharmaceuticals USA, Inc.3$61
Takeda Pharmaceuticals U.S.A., Inc.2$53
Otsuka America Pharmaceutical, Inc.3$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$48
Janssen Pharmaceuticals, Inc3$48
ABBVIE INC.3$46
E.R. Squibb & Sons, L.L.C.2$34

Products named: Auvelity, TRINTELLIX, REXULTI, CAPLYTA, UZEDY, VRAYLAR, COBENFY, INVEGA SUSTENNA.

Industry payments across OK — which companies pay providers there.